Streetbeat News

Products Services

CATX

LNTH

Perspective Therapeutics, Inc. (NYSE:CATX) has acquired a CGMP-compliant manufacturing facility from Lantheus Holdings, Inc. (NASDAQ:LNTH) to produce 203Pb- and 212Pb-labeled radiopharmaceuticals for cancer treatment. The facility, located in Somerset, New Jersey, will support clinical and potential commercial production. This acquisition, part of strategic agreements with Lantheus, aims to enhance Perspective's manufacturing capabilities and expedite the delivery of its radiopharmaceuticals. Lantheus has also agreed to purchase $57.4 million of Perspective's common stock as part of an investment agreement.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 1:12 pm

CPNG

Coupang (NYSE:CPNG), in partnership with the U.S. Department of Commerce and International Trade Administration, co-hosted EMPOWER Asia webinars aimed at promoting U.S. exports to South Korea, with a focus on women-owned businesses in the Food & Beverage and Apparel & Fashion industries. The webinars provided insights into Korea's commerce market, expected to exceed $563 billion by 2027, and offered guidance on leveraging Coupang's platform for cross-border trade. Speakers from various organizations shared their expertise on accessing the Korean market and succeeding on Coupang's platform.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 1:11 pm

PCRFY

TM

Toyota Motor Corporation (NYSE:TM) is set to acquire full ownership of Primearth EV Energy Co., Ltd. (PEVE), a joint venture with Panasonic Holdings Corporation (OTC:PCRFY), to expand its battery production for electric vehicles. This move aims to enhance Toyota's capabilities in mass-producing automotive batteries, including those for hybrid electric vehicles (HEVs), battery electric vehicles (BEVs), and plug-in hybrid electric vehicles (PHEVs), supporting Toyota's goal of carbon neutrality. The acquisition is expected to be completed in late March.

Portfolio Pulse from Shivani Kumaresan

March 05, 2024 | 1:10 pm

AMTX

Aemetis, Inc. has been granted the necessary air permits to proceed with the construction of its Riverbank Sustainable Aviation Fuel Plant. This development marks a significant step forward in the company's efforts to produce environmentally friendly aviation fuel.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 1:10 pm

MYNZ

Mainz Biomed has partnered with Trusted Health Advisors, led by Dr. Jay Wohlgemuth and Dr. Ray Tabibiazar, to support its U.S. market strategy for an early colorectal cancer diagnostic test. The company's pivotal FDA PMA clinical trial, ReconAAsense, for a self-administered colorectal cancer screening test is set to begin patient enrollment in 2024.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 1:04 pm

V

WU

Visa and Western Union have expanded their collaboration with a 7-year agreement enabling Western Union customers to send money to Visa cards and bank accounts in 40 countries. The deal includes issuing Western Union/Visa Debit Cards in North America, Asia Pacific, Latin America, and Europe, and using Visa Direct for quick fund transfers. Additionally, it will support humanitarian relief efforts with prepaid cards for government and NGO customers. This partnership aims to enhance global remittance services by leveraging Visa's global network and Western Union's digital capabilities.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 1:03 pm

CRVO

CervoMed Inc. (NASDAQ:CRVO) announced positive results from the AscenD-LB Phase 2a trial of neflamapimod for dementia with Lewy bodies (DLB), showing significant reduction in plasma GFAP levels compared to placebo. The reduction in GFAP correlated with improved clinical outcomes. Additionally, data from UCL demonstrated neflamapimod's potential in improving axonal transport in a tauopathy mouse model, supporting its use in frontotemporal dementia treatment. These findings will be presented at the AD/PD™ 2024 conference.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 1:01 pm

AAPL

VGT

XLK

Apple Inc's iPhone sales in China dropped 24% in the first six weeks of the year, placing it fourth among smartphone vendors in the country. The decline was attributed to a 7% contraction in China's overall smartphone market and strong performances by Vivo and Huawei, with Huawei's market share increasing to 16.5%. Apple's market share fell to 15.7%. In response, Apple introduced discounts and promotions. Investors can gain exposure to Apple through ETFs like Vanguard Information Tech ETF (VGT) and SPDR Select Sector Fund - Technology (XLK). AAPL shares dropped 2.25% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

March 05, 2024 | 12:55 pm

GANX

Gain Therapeutics announced to Benzinga that their data supports GT-02287's ability to prevent several steps in the disease cascade caused by GCase misfolding and dysfunction.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 12:45 pm

GANX

Gain Therapeutics announced it will present data at the AP/PD 2024 Conference on March 8 and 9, showcasing the mechanism of action of GT-02287, its GCase regulator for Parkinson's disease treatment.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 12:45 pm